PFBT
TNGX icon

Parkside Financial Bank & Trust’s Tango Therapeutics TNGX Stock Holding History

Parkside Financial Bank & Trust’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$733 Buy
+35
New +$487 ﹤0.01% 2452

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Parkside Financial Bank & Trust's TNGX Position: Q1 2026 in Review

Parkside Financial Bank & Trust opened a new position in Tango Therapeutics (TNGX) in Q1 2026: 35 shares worth $733. The stake represents ﹤0.01% of the portfolio and ranks #2452 among its holdings.

194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Parkside Financial Bank & Trust held 35 shares of Tango Therapeutics worth $733 as of Q1 2026.
  • Tango Therapeutics was a new Parkside Financial Bank & Trust position in Q1 2026.
  • Tango Therapeutics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2452 holding.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.